Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin vs Cetuximab with mFOLFOX6 in mCRC
NCT01338558Phase 3Withdrawn
- Sponsor
- Roche
- Start
- Jun 2011
- Primary completion
- May 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roche. Planned start Jun 2011; status: withdrawn.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01338558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01338558.